| Application no. and date | 04008908.8 (espacenet) (Federated) (European Patent Register), 20010523 | | Patent/reg. no. and date | DK/EP 1536234, 20160316 | | Publication date | 20050601 | | Priority no. and date | US 579927, 20000526, US 214065 P, 20000626 | | EP pub. no. and date |
EP 1536234 20050601 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Company, Route 206 and Province Line Road
Princeton, NJ 08543, US | | Applicant ref. no. | V136692DK | | Inventor | Peach, Robert J., 12848 Via Caballo Rojo
San Diego, Ca 92129, US,
Naemura, Joseph R., 2627 127th Avenue, NE
Bellevue,
Washington 98005, US,
Linsley, Peter S., 2430 9th Avenue W.
Seattle,
Washington 98119, US,
Bajorath, Jürgen, 17406 37th Avenue
Lynwood,
CA 98037, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | C07K 14/705 (2006.01) , G01N 33/68 (2006.01) | | Title | OPLØSELIGE MUTANTE CTLA4-MOLEKYLER OG ANVENDELSER DERAF | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
